Referencias:

• Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Immunosuppressive Strategies that are Mediated by Tumor Cells (2007) Annu Rev Immunol, 25, pp. 267-296
• Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells (2002) Annu Rev Immunol, 20, pp. 621-667
• Ishida, T., Oyama, T., Carbone, D., Gabrilovich, D.I., Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hematopoietic progenitors (1998) J Immunol, 161, pp. 4842-4851
• Hoffmann, T.K., Muller-Berghaus, J., Ferris, R.L., Johnson, J.T., Storkus, W.J., Whiteside, T.L., Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck (2002) Clin Cancer Res, 8, pp. 1787-1793
• Pinzon-Charry, A., Ho, C.S., Laherty, R., A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer (2005) Neoplasia, 7, pp. 1112-1122
• Troy, A.J., Summers, K.L., Davidson, P.J., Atkinson, C.H., Hart, D.N., Minimal recruitment and activation of dendritic cells within renal cell carcinoma (1998) Clin Cancer Res, 4, pp. 585-593
• Chaux, P., Favre, N., Martin, M., Martin, F., Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats (1997) Intern J Cancer, 72, pp. 619-624
• Enk, A.H., Jonuleit, H., Saloga, J., Knop, J., Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma (1997) Intern J Cancer, 73, pp. 309-316
• Nestle, F.O., Burg, G., Fah, J., Wrone-Smith, T., Nickoloff, B.J., Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells (1997) Am J Pathol, 150, pp. 641-651
• Colonna, M., Trinchieri, G., Liu, Y.J., Plasmacytoid dendritic cells in immunity (2004) Nat Immunol, 5, pp. 1219-1226
• Zou, W., Machelon, V., Coulomb-L'Hermin, A., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (2001) Nat Med, 7, pp. 1339-1346
• Hartmann, E., Wollenberg, B., Rothenfusser, S., Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer (2003) Cancer Res, 63, pp. 6478-6487
• Vermi, W., Bonecchi, R., Facchetti, F., Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas (2003) J Pathol, 200, pp. 255-268
• Munn, D.H., Sharma, M.D., Hou, D., Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes (2004) J Clin Invest, 114, pp. 280-290
• Kusmartsev, S., Gabrilovich, D.I., Immature myeloid cells and cancer-associated immune suppression (2002) Cancer Immunol Immunother, 51, pp. 293-298
• Bronte, V., Wang, M., Overwijk, W., Apoptotic death of CD8+ T lymphocytes after immunization: Induction of a suppressive population of Mac-1+/Gr-1+ cells (1998) J Immunol, 161, pp. 5313-5320
• Gabrilovich, D.I., Velders, M., Sotomayor, E., Kast, W.M., Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells (2001) J Immunol, 166, pp. 5398-5406
• Li, Q., Pan, P.Y., Gu, P., Xu, D., Chen, S.H., Role of immature myeloid Gr-1+ cells in the development of antitumor immunity (2004) Cancer Res, 64, pp. 1130-1139
• Terabe, M., Matsui, S., Park, J.M., Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumo immunosurveillance: Abrogation prevents tumor recurrence (2003) J Exp Med, 198, pp. 1741-1752
• Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D.I., Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species (2004) J Immunol, 172, pp. 989-999
• Kusmartsev, S., Nagaraj, S., Gabrilovich, D.I., Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells (2005) J Immunol, 175, pp. 4583-4592
• Huang, B., Pan, P.Y., Li, Q., Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host (2006) Cancer Res, 66, pp. 1123-1131
• Bronte, V., Serafini, P., De Santo, C., IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice (2003) J Immunol, 170, pp. 270-278
• Kusmartsev, S., Gabrilovich, D., STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion (2005) J Immunol, 174, pp. 4880-4891
• Almand, B., Clark, J.I., Nikitina, E., Increased production of immature myeloid cells in cancer patients. A mechanism of immunosuppression in cancer (2001) J Immunol, 166, pp. 678-689
• Danna, E.A., Sinha, P., Gilbert, M., Clements, V.K., Pulaski, B.A., Ostrand-Rosenberg, S., Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease (2004) Cancer Res, 64, pp. 2205-2211
• Schmielau, J., Finn, O.J., Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients (2001) Cancer Res, 61, pp. 4756-4760
• Mantovani, A., Schioppa, T., Porta, C., Allavena, P., Sica, A., Role of tumor-associated macrophages in tumor progression and invasion (2006) Cancer Metastasis Rev, 25, pp. 315-322
• Talks, K.L., Turley, H., Gatter, K.C., The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages (2000) Am J Pathol, 157, pp. 411-421
• Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes (2002) Trends Immunol, 23, pp. 549-555
• Luo, Y., Zhou, H., Krueger, J., Targeting tumor-associated macrophages as a novel strategy against breast cancer (2006) J Clin Invest, 116, pp. 2132-2141
• Toscano, M.A., Ilarregui, J.M., Bianco, G.A., Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity? (2007) Cytokine Growth Factor Rev, 18, pp. 57-71
• Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J Immunol, 178, pp. 436-445
• Sakaguchi, S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses (2004) Annu Rev Immunol, 22, pp. 531-562
• Zou, W., Immunosuppressive networks in the tumour environment and their therapeutic relevance (2005) Nat Rev Cancer, 5, pp. 263-274
• Curiel, T.J., Coukos, G., Zou, L., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (2004) Nat Med, 10, pp. 942-949
• Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109, pp. 2058-2065
• Kubach, J., Lutter, P., Bopp, T., Human CD4+CD25+ regulatory T cells: Proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function (2007) Blood, , in press
• Rabinovich, G.A., Daly, G., Dreja, H., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J Exp Med, 190, pp. 385-398
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Santucci, L., Fiorucci, S., Rubinstein, N., Galectin-1 suppresses experimental colitis in mice (2003) Gastroenterology, 124, pp. 1381-1394
• Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated antiinflammatory responses (2006) J Immunol, 176, pp. 6323-6332
• Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., Nakayama, E., Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody (1999) Cancer Res, 59, pp. 3128-3133
• Shimizu, J., Yamazaki, S., Sakaguchi, S., Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity (1999) J Immunol, 163, pp. 5211-5218
• Shevach, E.M., Stephens, G.L., The GITR-GITRL interaction: Co-stimulation or contrasuppression of regulatory activity? (2006) Nat Rev Immunol, 6, pp. 613-618
• Pasare, C., Medzhitov, R., Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells (2003) Science, 299, pp. 1033-1036
• Peng, G., Guo, Z., Kiniwa, Y., Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function (2005) Science, 309, pp. 1380-1384
• Emolini, A.M., Ladle, B.H., Manning, E.A., Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response (2005) J Exp Med, 201, pp. 1591-1602
• Zacarias Fluck, M.F., Rico, M.J., Gervasoni, S.I., Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model (2007) Cancer Immunol Immunother, 56, pp. 237-248
• O'Garra, A., Vieira, P.L., Vieira, P., Goldfeld, A.E., IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage (2004) J Clin Invest, 114, pp. 1372-1378
• Taams, L.S., Palmer, D.B., Akbar, A.N., Robinson, D.S., Brown, Z., Hawrylowicz, C.M., Regulatory T cells in human disease and their potential for therapeutic manipulation (2006) Immunology, 118, pp. 1-9
• Fiore, F., Nuschak, B., Peola, S., Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells (2005) Eur J Immunol, 35, pp. 1155-1163
• Terabe, M., Matsui, S., Noben-Trauth, N., NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway (2000) Nat Immunol, 1, pp. 515-520

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------